EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Multi‐Target‐Directed Ligands ( MTDLs ) as Potential Therapeutic Candidates Targeting Multiple Pathogenic Factor of Alzheimer's Disease

Jaewoon Jung, Yebeen Kim, Asifiwe Clarisse Cirunduzi, Seonghyun Yoon, Seokyoung Bang, Seung-Hoon Yang

CNS Neuroscience & Therapeutics · 2026-05 · 32 (5)

DOI: 10.1002/cns.70919 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 18.05.2026. Verfasst von Jaewoon Jung und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, College of Life Science and Biotechnology, Dongguk University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Research Foundation of Korea, Korea Environment Industry & Technology Institute (KEITI) through Technology Development Project for Safety Management of Household Chemical Products, Korea Ministry of Environment (MOE).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alzheimer's disease (AD) is the most common cause of dementia and a chronic neurodegenerative disorder in older adults. AD is not driven by a single factor but by the interaction of multiple pathological processes, including amyloid‐β (Aβ) accumulation, tau hyperphosphorylation, and chronic neuroinflammation. Aβ aggregates into plaques that disrupt neuronal signaling, while hyperphosphorylated tau forms neurofibrillary tangles, leading to neuronal loss. These processes act synergistically to amplify toxicity. Persistent activation of microglia and astrocytes further promotes neuroinflammation, worsening Aβ and tau pathology. Current Limitations Single‐target therapies directed at Aβ or tau have shown limited clinical success and failed to alter disease progression, underscoring the complexity of AD.

Objectives

In response, multi‐target‐directed ligands (MTDLs) have emerged as a promising strategy. By simultaneously modulating several disease pathways, MTDLs can inhibit Aβ aggregation, reduce tau phosphorylation, and exert antioxidant and anti‐inflammatory effects. This review summarizes recent progress on MTDLs, highlighting their mechanisms of action, representative drug candidates, and outcomes from preclinical and clinical studies.

Conclusions

Multi‐target strategies have the potential to achieve more effective and disease‐modifying outcomes than conventional approaches. A critical evaluation of their opportunities and challenges may guide future therapeutic development and the advancement of precision medicine for Alzheimer's disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-PeptidesHumansAnimalstau ProteinsLigandsMolecular Targeted TherapyNeuroinflammatory DiseasesPhosphorylation

Stichwörter der Autor:innen

Alzheimer's disease (AD)amyloid‐β (aβ)multi‐target‐directed ligands (MTDLs)neuroinflammationtau

Substanzen

Amyloid beta-Peptidestau ProteinsLigands

Autor:innen und Institutionen

  • Department of Biomedical Engineering, College of Life Science and Biotechnology, Dongguk University, Seoul, Republic of Korea.

Förderung

  • The National Research Foundation of Korea
  • Korea Environment Industry & Technology Institute (KEITI) through Technology Development Project for Safety Management of Household Chemical Products
  • Korea Ministry of Environment (MOE)
  • National Research Foundation of Korea
  • Korea Environmental Industry and Technology Institute

Zitieren

APA

Jung, J., Kim, Y., Cirunduzi, A. C., Yoon, S., Bang, S., & Yang, S. H. (2026). Multi‐Target‐Directed Ligands ( MTDLs ) as Potential Therapeutic Candidates Targeting Multiple Pathogenic Factor of Alzheimer's Disease. CNS Neuroscience & Therapeutics, 32(5). https://doi.org/10.1002/cns.70919

Vancouver

Jung J, Kim Y, Cirunduzi AC, Yoon S, Bang S, Yang SH. Multi‐Target‐Directed Ligands ( MTDLs ) as Potential Therapeutic Candidates Targeting Multiple Pathogenic Factor of Alzheimer's Disease. CNS Neuroscience & Therapeutics. 2026;32(5). doi:10.1002/cns.70919

BibTeX
@article{Jung2026,
  author = {Jung, Jaewoon and Kim, Yebeen and Cirunduzi, Asifiwe Clarisse and Yoon, Seonghyun and Bang, Seokyoung and Yang, Seung-Hoon},
  title = {Multi‐Target‐Directed Ligands ( MTDLs ) as Potential Therapeutic Candidates Targeting Multiple Pathogenic Factor of Alzheimer's Disease},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {5},
  doi = {10.1002/cns.70919}
}
Kostenlos starten →